INFORMAZIONI SU QUESTO EPISODIO
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention Center in Providence.
The two-day symposium, themed “Precision Oncology: Innovation and Equity Across the Globe,” will bring together researchers, clinicians, healthcare professionals, industry leaders, and other experts from around the world to explore advances in precision oncology and strategies for improving personalized cancer care.
The WIN Consortium is chaired by Wafik S. El-Deiry, MD, PhD, FACP, who also serves as Editor-in-Chief of Oncotarget. Dr. El-Deiry is also the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
As a peer-reviewed oncology journal dedicated to publishing impactful cancer research, Oncotarget is pleased to support initiatives that encourage international collaboration and advance innovative approaches to cancer prevention, diagnosis, and treatment.
Full press release - https://www.oncotarget.com/news/pr/oncotarget-supports-win-2026-symposium-advancing-precision-oncology/
To learn more about the symposium and registration, visit https://winconsortium.org/symposia
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
Facebook - www.facebook.com/Oncotarget/
X - twitter.com/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/@OncotargetJournal
LinkedIn - www.linkedin.com/company/oncotarget
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/
Spotify - open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
The two-day symposium, themed “Precision Oncology: Innovation and Equity Across the Globe,” will bring together researchers, clinicians, healthcare professionals, industry leaders, and other experts from around the world to explore advances in precision oncology and strategies for improving personalized cancer care.
The WIN Consortium is chaired by Wafik S. El-Deiry, MD, PhD, FACP, who also serves as Editor-in-Chief of Oncotarget. Dr. El-Deiry is also the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
As a peer-reviewed oncology journal dedicated to publishing impactful cancer research, Oncotarget is pleased to support initiatives that encourage international collaboration and advance innovative approaches to cancer prevention, diagnosis, and treatment.
Full press release - https://www.oncotarget.com/news/pr/oncotarget-supports-win-2026-symposium-advancing-precision-oncology/
To learn more about the symposium and registration, visit https://winconsortium.org/symposia
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
Facebook - www.facebook.com/Oncotarget/
X - twitter.com/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/@OncotargetJournal
LinkedIn - www.linkedin.com/company/oncotarget
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/
Spotify - open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Oncotarget.
ALTRI EPISODI IN QUESTO PODCAST
BUFFALO, NY – September 9, 2026 – A new #review was #published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.”
The review examines emerging strategies to restore major histocompatibility complex class I (MHC-I) expression in cancers of the ce…
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge in head and neck cancer care. Human papillomavirus (HPV), particularly HPV type…
BUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.”
The editorial was led by first and corresponding author Bhartendra Shar…
BUFFALO, NY – September 1, 2026 – A new #review was published in Volume 17 of Oncotarget on August 28, 2026, titled “Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational ch…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Oncotarget Podcast, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
